Bicarbonate

Bicarbonate

SCHEMBL19664202

O=C([O-])O.O=C([O-])O.O=C([O-])O.[H+].[Na+].[Na+]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.55
FAHD1 Q6P587 1/20 0.55
CA1 P00915 3/20 0.50
MEN1 O00255 1/20 0.43
LDHA P00338 1/20 0.43
BLM P54132 1/20 0.43
KMT2A Q03164 1/20 0.43
CA2 P00918 2/20 0.40
LMNA P02545 2/20 0.40
CASP1 P29466 1/20 0.40
CA9 Q16790 1/20 0.40
FFAR3 O14843 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL931293 1.00
Bicarbonate SCHEMBL7713688 0.95 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL3395196 0.95 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL15666483 0.95 CA4 (0.50) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL28340034 0.95
Bicarbonate SCHEMBL1332486 0.94
Bicarbonate SCHEMBL83 0.94
Bicarbonate SCHEMBL1332636 0.94
Bicarbonate SCHEMBL15321596 0.94 CA4 (0.60) CA4FAHD1CA1MEN1LDHA
Bicarbonate SCHEMBL5403678 0.94 CA4 (0.60) CA4FAHD1CA1MEN1LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252041-B1 BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL SUMITOMO CHEMICAL CO (JP) 2020-03-04 EP disclosed
US-10173997-B2 Bipyridine compound and use of same for noxious arthropod control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-01-08 US disclosed
US-20180009778-A1 BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-11 US disclosed
EP-3252041-A1 BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL Sumitomo Chemical Company, Limited (JP) 2017-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180009778-A1 BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL BBOX1, ACHE, MORF4L1 CA4 2078/4885FAHD1 3877/4885CA1 1554/4885
US-10173997-B2 Bipyridine compound and use of same for noxious arthropod control BBOX1, ACHE, MORF4L1 CA4 2078/4885FAHD1 3877/4885CA1 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.